Evaluation of a new turbidimetric assay for von Willebrand factor activity useful in the general screening of von Willebrand disease.

Abstract

We evaluated a new assay (HemosIL VWF Activity on ACL-Futura) in the screening of VWD. Samples from healthy donors and previously diagnosed VWD patients were blindly analyzed by this new activity assay and standard VWF:RCo. Results agreed and both assays showed a similar sensitivity for the screening of VWD. 

Topics

2 Figures and Tables

Slides referencing similar topics